Clinical Study
Two-Stage Revision Arthroplasty for Periprosthetic Hip Infection: Mean Follow-Up of Ten Years
Table 2
Diagnosis and surgical procedures.
| Diseases for arthroplasty (osteonecrosis/fracture/osteoarthritis/autoimmune/other) | 62 (39%)/44 (28%)/43 (27%)/5 (3%)/3 (2%) | Index procedure (primary THA/revised THA/hemiarthroplasty) | 72 (46%)/44 (28%)/41 (26%) | Cementation in index OP (cementless/hybrid/full cementation) | 129 (82%)/22 (14%)/6 (4%) | C-reactive protein level before revision OP (mg/L) | 10.5 ± 17 (0.3–96) | Erythrocyte sedimentation rate before revision OP (mm/hr) | 25.1 ± 18 (2–72) | Revision prosthesis (cage/megaprosthesis) | 21 (13%)/1 (0.6%) | Cementation in revision (cementless/hybrid/full cementation) | 122 (78%)/31 (20%)/4 (2%) | Bone grafting in revision (no/morselized allograft/onlay allograft/allograft-prosthesis composite) | 125 (79%)/26 (17%)/3 (2%)/3 (2%) |
|
|
Data are number (%) of episodes or mean ± standard deviation (range). THA: total hip arthroplasty; OP: operation.
|